Nilutamide

Nilutamide

SCHEMBL115340

CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1.CC1(C)NC(=O)N(c2ccc([N+](=O)[O-])c(C(F)(F)F)c2)C1=O

nearest known ligand 0.73

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AR

The experimentally established mechanism targets of Nilutamide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR known ✓ P10275 11/20 0.73
CYP3A4 P08684 3/20 0.73
LMNA P02545 2/20 0.73
CYP1A2 P05177 2/20 0.73
CYP2C9 P11712 2/20 0.73
TSHR P16473 2/20 0.73
CYP2C19 P33261 2/20 0.73
SMN1; SMN2 Q16637 2/20 0.73
PGR P06401 2/20 0.73
MEN1 O00255 1/20 0.73
TP53 P04637 1/20 0.73
CYP2D6 P10635 1/20 0.73
ALOX12 P18054 1/20 0.73
NFKB1 P19838 1/20 0.73
RAB9A P51151 1/20 0.73
KMT2A Q03164 1/20 0.73
PDE4D Q08499 1/20 0.73
NPSR1 Q6W5P4 1/20 0.73
CES2 O00748 1/20 0.67
ABCB11 O95342 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Nilutamide SCHEMBL12670 0.85 AR (1.00) ARCYP3A4LMNACYP1A2CYP2C9
Nilutamide SCHEMBL29351021 0.85 AR (1.00) ARCYP3A4LMNACYP1A2CYP2C9
Nilutamide SCHEMBL1462011 0.85 AR (1.00) ARCYP3A4LMNACYP1A2CYP2C9
Nilutamide SCHEMBL20695037 0.84 AR (0.89) ARCYP3A4LMNACYP1A2CYP2C9
Nilutamide SCHEMBL28562851 0.84 AR (0.98) ARCYP3A4LMNACYP1A2CYP2C9
Nilutamide SCHEMBL5579273 0.82 AR (0.89) ARCYP3A4LMNACYP1A2CYP2C9
Flutamide SCHEMBL29349783 0.82 AR (1.00) ARCYP3A4LMNACYP1A2CYP2C9
Flutamide SCHEMBL3934 0.82 AR (1.00) ARCYP3A4LMNACYP1A2CYP2C9
Flutamide SCHEMBL1461845 0.82 AR (1.00) ARCYP3A4LMNACYP1A2CYP2C9
Bicalutamide SCHEMBL15110318 0.81 AR (0.60) ARCYP2C19PGRABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110062767-A Human antibody, pharmaceutical composition and method 台湾浩鼎生技股份有限公司 2019-07-26 CN claimed
CN-110062767-A Human antibody, pharmaceutical composition and method 台湾浩鼎生技股份有限公司 2019-07-26 CN disclosed
CN-103717597-B Heterocyclic compounds as kinase inhibitors 原真股份有限公司 2017-07-04 CN disclosed
CN-103492389-B Pyrazolo [4,3-d] pyrimidine as inhibitors of kinases 原真股份有限公司 2016-09-14 CN disclosed
EP-2424853-A2 NON-STEROIDAL COMPOUNDS FOR ANDROGEN RECEPTOR MODULATION, PROCESSES FOR THE PREPARATION AND USES THEREOF Consiglio Nazionale Delle Ricerche (IT) 2012-03-07 EP disclosed
WO-2010116342-A2 NON-STEROIDAL COMPOUNDS FOR ANDROGEN RECEPTOR MODULATION CONSIGLIO NAZIONALE DELLE RICERCHE (IT) 2010-10-14 WO disclosed